Siglec-E Protein Deficiency Worsens Heart Failure After Heart Attack
Heart attack survivors face a critical window where their immune response determines whether they develop heart failure or recover with minimal damage. This ba…
Found 1137 results for "cancer"
Heart attack survivors face a critical window where their immune response determines whether they develop heart failure or recover with minimal damage. This ba…
Blood cancer patients facing the grimmest prognoses now have access to a potentially game-changing treatment approach that combines gentler stem cell transplan…
Cancer patients receiving targeted immunotherapy may face an unexpected challenge beyond tumor treatment: their therapeutic antibodies can trigger destruction…
Cancer treatment could gain a powerful new combination as researchers discover how an existing immunosuppressive drug dramatically amplifies the cancer-killing…
Cancer cells may have a fatal weakness to copper toxicity that researchers are now learning to exploit therapeutically. This vulnerability stems from cancer's…
Cancer prevention strategies may need fundamental revision following evidence that cells with intact DNA repair systems can still suffer catastrophic genetic d…
Understanding genetic cancer susceptibility just became more precise for families carrying specific inherited mutations. A comprehensive analysis of over 1,300…
A breakthrough in understanding why a highly effective lung cancer medication causes heart problems could transform how oncologists balance treatment benefits…
Advanced spatial analysis reveals that bacteria living directly within tumors—distinct from gut microbiota—actively modify cancer cell genomic stability, metab…
A 55-year-old woman with prediabetes experienced paradoxical glycemic deterioration within one month of starting semaglutide 0.25 mg weekly, with fasting gluco…
The promise of precision cancer medicine faces a sobering reality check in pediatric oncology, where even molecularly targeted approaches struggle against aggr…
Brain cancer remains one of medicine's most stubborn challenges, with immunotherapies that revolutionize other cancers often failing against glioblastoma. The…
The deadliest brain cancer may have found an unexpected metabolic accomplice in the cells meant to support healthy neurons. This discovery reveals how glioblas…
Cancer cells may soon face a more formidable opponent as researchers develop photosensitizers that simultaneously attack multiple cellular weak points. Traditi…
The stark difference in cancer remission rates between two FDA-approved immunotherapies may finally have an explanation that could reshape treatment selection…
Daily bread consumption may pose a greater cancer risk than previously recognized, as industrial baking processes introduce measurable levels of carcinogenic c…
A fundamental shift in cancer biology understanding is emerging as researchers identify how cellular aging within tumors actually accelerates malignancy rather…
Cancer immunotherapy may have reached a pivotal turning point with the demonstration that CAR-T cells can be engineered directly inside patients' bodies, poten…
The promise of gene therapy as a transformative medical intervention faces a sobering reminder that even advanced therapeutic vectors carry inherent risks requ…
Gene therapy's promise of curing inherited diseases faces a sobering reality check as clinicians confront the rare but serious risk of treatment-induced cancer…